HOME
BACK
Q5T1H1 Proteins EGF-like domain Repeats
Uniprot ID:Q5T1H1
Protein name: Protein eyes shut homolog
Gene : EYS C6orf178 C6orf179 C6orf180 EGFL10 EGFL11 SPAM UNQ9424/PRO34591
Protein Family:EYS family
Squence Length : 3165
Sequnce
>Q5T1H1 3166 MTDKSIVILSLMVFHSSFINGKTCRRQLVEEWHPQPSSYVVNWTLTENICLDFYRDCWFLGVNTKIDTSGNQAVPQICPLQIQLGDILVISSEPSLQFPEINLMNVSETSFVGCVQNTTTEDQLLFGCRLKGMHTVNSKWLSVGTHYFITVMASGPSPCPLGLRLNVTVKQQFCQESLSSEFCSGHGKCLSEAWSKTYSCHCQPPFSGKYCQELDACSFKPCKNNGSCINKRENWDEQAYECVCHPPFTGKNCSEIIGQCQPHVCFHGNCSNITSNSFICECDEQFSGPFCEVSAKPCVSLLFWKRGICPNSSSAYTYECPKGSSSQNGETDVSEFSLVPCQNGTDCIKISNDVMCICSPIFTDLLCKSIQTSCESFPLRNNATCKKCEKDYPCSCISGFTEKNCEKAIDHCKLLSINCLNEEWCFNIIGRFKYVCIPGCTKNPCWFLKNVYLIHQHLCYCGVTFHGICQDKGPAQFEYVWQLGFAGSEGEKCQGVIDAYFFLAANCTEDATYVNDPEDNNSSCWFPHEGTKEICANGCSCLSEEDSQEYRYLCFLRWAGNMYLENTTDDQENECQHEAVCKDEINRPRCSCSLSYIGRLCVVNVDYCLGNHSISVHGLCLALSHNCNCSGLQRYERNICEIDTEDCKSASCKNGTTSTHLRGYFFRKCVPGFKGTQCEIDIDECASHPCKNGATCIDQPGNYFCQCVPPFKVVDGFSCLCNPGYVGIRCEQDIDDCILNACEHNSTCKDLHLSYQCVCLSDWEGNFCEQESNECKMNPCKNNSTCTDLYKSYRCECTSGWTGQNCSEEINECDSDPCMNGGLCHESTIPGQFVCLCPPLYTGQFCHQRYNLCDLLHNPCRNNSTCLALVDANQHCICREEFEGKNCEIDVKDCLFLSCQDYGDCEDMVNNFRCICRPGFSGSLCEIEINECSSEPCKNNGTCVDLTNRFFCNCEPEYHGPFCELDVNKCKISPCLDEENCVYRTDGYNCLCAPGYTGINCEINLDECLSEPCLHDGVCIDGINHYTCDCKSGFFGTHCETNANDCLSNPCLHGRCTELINEYPCSCDADGTSTQCKIKINDCTSIPCMNEGFCQKSAHGFTCICPRGYTGAYCEKSIDNCAEPELNSVICLNGGICVDGPGHTFDCRCLPGFSGQFCEININECSSSPCLHGADCEDHINGYVCKCQPGWSGHHCENELECIPNSCVHELCMENEPGSTCLCTPGFMTCSIGLLCGDEIRRITCLTPIFQRTDPISTQTYTIPPSETLVSSFPSIKATRIPAIMDTYPVDQGPKQTGIVKHDILPTTGLATLRISTPLESYLLQELIVTRELSAKHSLLSSADVSSSRFLNFGIRDPAQIVQDKTSVSHMPIRTSAATLGFFFPDRRARTPFIMSSLMSDFIFPTQSLLFENCQTVALSATPTTSVIRSIPGADIELNRQSLLSRGFLLIAASISATPVVSRGAQEDIEEYSADSLISRREHWRLLSPSMSPIFPAKVIISKQVTILNSSALHRFSTKAFNPSEYQAITEASSNQRLTNIKSQAADSLRELSQTCATCSMTEIKSSREFSDQVLHSKQSHFYETFWMNSAILASWYALMGAQTITSGHSFSSATEITPSVAFTEVPSLFPSKKSAKRTILSSSLEESITLSSNLDVNLCLDKTCLSIVPSQTISSDLMNSDLTSKMTTDELSVSENILKLLKIRQYGITMGPTEVLNQESLLDMEKSKGSHTLFKLHPSDSSLDFELNLQIYPDVTLKTYSEITHANDFKNNLPPLTGSVPDFSEVTTNVAFYTVSATPALSIQTSSSMSVIRPDWPYFTDYMTSLKKEVKTSSEWSKWELQPSVQYQEFPTASRHLPFTRSLTLSSLESILAPQRLMISDFSCVRYYGDSYLEFQNVALNPQNNISLEFQTFSSYGLLLYVKQDSNLVDGFFIQLFIENGTLKYHFYCPGEAKFKSINTTVRVDNGQKYTLLIRQELDPCNAELTILGRNTQICESINHVLGKPLPKSGSVFIGGFPDLHGKIQMPVPVKNFTGCIEVIEINNWRSFIPSKAVKNYHINNCRSQGFMLSPTASFVDASDVTQGVDTMWTSVSPSVAAPSVCQQDVCHNGGTCHAIFLSSGIVSFQCDCPLHFTGRFCEKDAGLFFPSFNGNSYLELPFLKFVLEKEHNRTVTIYLTIKTNSLNGTILYSNGNNCGKQFLHLFLVEGRPSVKYGCGNSQNILTVSANYSINTNAFTPITIRYTTPVGSPGVVCMIEMTADGKPPVQKKDTEISHASQAYFESMFLGHIPANVQIHKKAGPVYGFRGCILDLQVNNKEFFIIDEARHGKNIENCHVPWCAHHLCRNNGTCISDNENLFCECPRLYSGKLCQFASCENNPCGNGATCVPKSGTDIVCLCPYGRSGPLCTDAINITQPRFSGTDAFGYTSFLAYSRISDISFHYEFHLKFQLANNHSALQNNLIFFTGQKGHGLNGDDFLAVGLLNGSVVYSYNLGSGIASIRSEPLNLSLGVHTVHLGKFFQEGWLKVDDHKNKSIIAPGRLVGLNVFSQFYVGGYSEYTPDLLPNGADFKNGFQGCIFTLQVRTEKDGHFRGLGNPEGHPNAGRSVGQCHASPCSLMKCGNGGTCIESGTSVYCNCTTGWKGSFCTETVSTCDPEHDPPHHCSRGATCISLPHGYTCFCPLGTTGIYCEQALILIVILEKPKPAERKVKKEALSISDPSFRSNELSWMSFASFHVRKKTHIQLQFQPLAADGILFYAAQHLKAQSGDFLCISLVNSSVQLRYNLGDRTIILETLQKVTINGSTWHIIKAGRVGAEGYLDLDGINVTEKASTKMSSLDTNTDFYIGGVSSLNLVNPMAIENEPVGFQGCIRQVIINNQELQLTEFGAKGGSNVGDCDGTACGYNTCRNGGECTVNGTTFSCRCLPDWAGNTCNQSVSCLNNLCLHQSLCIPDQSFSYSCLCTLGWVGRYCENKTSFSTAKFMGNSYIKYIDPNYRMRNLQFTTISLNFSTTKTEGLIVWMGIAQNEENDFLAIGLHNQTLKIAVNLGERISVPMSYNNGTFCCNKWHHVVVIQNQTLIKAYINNSLILSEDIDPHKNFVALNYDGICYLGGFEYGRKVNIVTQEIFKTNFVGKIKDVVFFQEPKNIELIKLEGYNVYDGDEQNEVT
Domains
DOMAIN 170 212 EGF-like 1 DOMAIN 213 254 EGF-like 2 DOMAIN 256 292 EGF-like 3 DOMAIN 332 368 EGF-like 4 DOMAIN 370 406 EGF-like 5 DOMAIN 567 602 EGF-like 6 DOMAIN 643 679 EGF-like 7 DOMAIN 681 720 EGF-like 8 calcium-binding DOMAIN 733 769 EGF-like 9 calcium-binding DOMAIN 771 807 EGF-like 10 calcium-binding DOMAIN 809 847 EGF-like 11 DOMAIN 849 888 EGF-like 12 DOMAIN 890 926 EGF-like 13 DOMAIN 928 964 EGF-like 14 calcium-binding DOMAIN 966 1002 EGF-like 15 DOMAIN 1004 1040 EGF-like 16 calcium-binding DOMAIN 1042 1077 EGF-like 17 DOMAIN 1079 1115 EGF-like 18 DOMAIN 1117 1159 EGF-like 19 DOMAIN 1161 1197 EGF-like 20 calcium-binding DOMAIN 1883 2063 Laminin G-like 1 DOMAIN 2099 2140 EGF-like 21 DOMAIN 2145 2339 Laminin G-like 2 DOMAIN 2335 2368 EGF-like 22 DOMAIN 2371 2408 EGF-like 23 DOMAIN 2419 2609 Laminin G-like 3 DOMAIN 2610 2646 EGF-like 24 DOMAIN 2648 2689 EGF-like 25 DOMAIN 2717 2895 Laminin G-like 4 DOMAIN 2896 2932 EGF-like 26 DOMAIN 2933 2970 EGF-like 27 DOMAIN 2975 3165 Laminin G-like 5
EGF-like sequence regions
170 - 212 QFCQESLSSEFCSGHGKCLSEAWSKTYSCHCQPPFSGKYCQEL 213 - 254 DACSFKPCKNNGSCINKRENWDEQAYECVCHPPFTGKNCSEI 256 - 292 GQCQPHVCFHGNCSNITSNSFICECDEQFSGPFCEVS 332 - 368 SEFSLVPCQNGTDCIKISNDVMCICSPIFTDLLCKSI 370 - 406 TSCESFPLRNNATCKKCEKDYPCSCISGFTEKNCEKA 567 - 602 DDQENECQHEAVCKDEINRPRCSCSLSYIGRLCVVN 643 - 679 EDCKSASCKNGTTSTHLRGYFFRKCVPGFKGTQCEID 681 - 720 DECASHPCKNGATCIDQPGNYFCQCVPPFKVVDGFSCLCN 733 - 769 DDCILNACEHNSTCKDLHLSYQCVCLSDWEGNFCEQE 771 - 807 NECKMNPCKNNSTCTDLYKSYRCECTSGWTGQNCSEE 809 - 847 NECDSDPCMNGGLCHESTIPGQFVCLCPPLYTGQFCHQR 849 - 888 NLCDLLHNPCRNNSTCLALVDANQHCICREEFEGKNCEID 890 - 926 KDCLFLSCQDYGDCEDMVNNFRCICRPGFSGSLCEIE 928 - 964 NECSSEPCKNNGTCVDLTNRFFCNCEPEYHGPFCELD 966 - 1002 NKCKISPCLDEENCVYRTDGYNCLCAPGYTGINCEIN 1004 - 1040 DECLSEPCLHDGVCIDGINHYTCDCKSGFFGTHCETN 1042 - 1077 NDCLSNPCLHGRCTELINEYPCSCDADGTSTQCKIK 1079 - 1115 NDCTSIPCMNEGFCQKSAHGFTCICPRGYTGAYCEKS 1117 - 1159 DNCAEPELNSVICLNGGICVDGPGHTFDCRCLPGFSGQFCEIN 1161 - 1197 NECSSSPCLHGADCEDHINGYVCKCQPGWSGHHCENE 2099 - 2140 SVCQQDVCHNGGTCHAIFLSSGIVSFQCDCPLHFTGRFCEKD 2335 - 2368 PWCAHHLCRNNGTCISDNENLFCECPRLYSGKLC 2371 - 2408 ASCENNPCGNGATCVPKSGTDIVCLCPYGRSGPLCTDA 2610 - 2646 SPCSLMKCGNGGTCIESGTSVYCNCTTGWKGSFCTET 2648 - 2689 STCDPEHDPPHHCSRGATCISLPHGYTCFCPLGTTGIYCEQA 2896 - 2932 TACGYNTCRNGGECTVNGTTFSCRCLPDWAGNTCNQS 2933 - 2970 VSCLNNLCLHQSLCIPDQSFSYSCLCTLGWVGRYCENK
Function
Required to maintain the integrity of photoreceptor cells
Disease
"DISEASE: Retinitis pigmentosa 25 (RP25) [MIM:602772]: A retinal dystrophy belonging to the group of pigmentary retinopathies Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors Patients typically have night vision blindness and loss of midperipheral visual field As their condition progresses, they lose their far peripheral visual field and eventually central vision as well Note=The disease is caused by mutations affecting the gene represented in this entry"